NEW YORK, Aug. 7, 2017 /PRNewswire-USNewswire/ -- NYU Langone's Perlmutter Cancer Center—a National Cancer Institute-designated Cancer Center—is expanding clinical and research activities on Long Island with the opening of a new, state-of-the-art facility in Huntington.
The new location more than doubles the size of Perlmutter's cancer program in the community, when combined with NYU Langone Huntington Medical Group in Huntington Station, one of the health system's largest ambulatory practices and a prominent fixture on Long Island since the 1950s. Equally important, it brings the clinical excellence of Perlmutter Cancer Center closer to where Long Islanders live and work.
The Perlmutter Cancer Center location in Huntington expects to see more than 30 thousand patient visits a year, providing infusion treatments for cancer, as well as conditions like Crohn's disease, multiple sclerosis, rheumatoid and psoriatic arthritis and lupus, among others.
Much like Perlmutter Cancer Center's facilities in Manhattan at other boroughs, the Huntington location features diagnostic laboratory support, private and open infusion bays, physician offices, complimentary refreshments, patient televisions and Wi-Fi. Patients also can access up-to-date medical records and test results, manage appointments, and communicate with their physicians using NYU Langone's system-wide electronic health record system Epic, and Epic's patient portal, MyChart.
"We understand the impact cancer has on individuals, families and communities, and the burden of trying to access the highest quality of care miles away in Manhattan," says Benjamin G. Neel, MD, PhD, director of Perlmutter Cancer Center. "With the opening of our site in Huntington, we can bring our services directly to Long Island patients who want to be treated at our world-class cancer center."
Mortality rates on Long Island from cancer--for both men and women--continue to be highest in Suffolk County, according to data from the New York State Department of Health, with lung, breast, colorectal, colon and pancreatic cancers leading the way. "By bringing our state-of-the art, cutting-edge care directly to the community, we hope to improve these unacceptable outcomes," says Neel.
Perlmutter Cancer Center provides the same level of world-class, personalized care at all of its locations throughout Manhattan, Brooklyn, Queens, and Long Island. Its interdisciplinary team of physicians and scientists work together to bring patients the most cutting-edge cancer treatments, like immunotherapy, cancer genetics/targeted therapies and epigenetics, imaging, community outreach and supportive oncology, and innovative clinical trials.
For More Information about this Location:
Perlmutter Cancer Center–Huntington
789 Park Avenue
Huntington, NY 11743
Deborah (DJ) Haffeman
About NYU Langone Health
NYU Langone Health is a world-class, patient-centered, integrated academic medical center, known for its excellence in clinical care, research, and education. Included in the 200+ locations throughout the New York area are five inpatient locations: Tisch Hospital, its flagship acute-care facility; Rusk Rehabilitation, ranked as one of the top 10 rehabilitation programs in the country; NYU Langone Orthopedic Hospital, a dedicated inpatient orthopedic hospital with all musculoskeletal specialties ranked top 10 in the country; Hassenfeld Children's Hospital at NYU Langone, a comprehensive pediatric hospital supporting a full array of children's health services; and NYU Langone Hospital—Brooklyn, a full-service teaching hospital and level 1 trauma center located in Sunset Park, Brooklyn. Also part of NYU Langone Health is the Laura and Isaac Perlmutter Cancer Center, a National Cancer Institute–designated cancer center, and NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. For more information, go to nyulangone.org, and interact with us on Facebook, Twitter, YouTube, and Instagram.
SOURCE NYU Langone Health